Biotech Research Breakthroughs, Collaborations, and Economic Incentives to Be Announced at BIO 2005

Jun 13, 2005, 01:00 ET from Biotechnology Industry Organization

    WASHINGTON, June 13 /PRNewswire/ -- A number of state and international
 economic development agencies and private companies will make announcements to
 the press at a special venue during the BIO 2005 Annual International
 Convention, June 19-22 at the Pennsylvania Convention Center in Philadelphia.
 The press conferences will spotlight scientific advancements, new research
 agreements, and biotech business opportunities around the world.  The schedule
 of press conferences, listed in chronological order, includes the following:
     * Government of India -- Recent Policy Developments
       Will Make India a Hotbed for Biotech
       Kapil Sibal, Indian Minister for Science & Technology,
       Amar Singh, Member of Parliament, and others will
       outline why India is fast emerging as a significant
       biotechnology hotbed in the Asia-Pacific region.
       Sunday, June 19 at 10:00 am, Room 203B
       Contact: Kapil Sibal, 24 64 1074
     * Queensland, Australia -- Biotechnology Breakthroughs
       The Honourable Peter Beattie, MP, Premier of
       Queensland, will announce breakthroughs in research and
       development within Queensland's biotechnology industry.
       His announcement will highlight R&D funding
       commitments, new industry partnerships, new research
       collaborations, and significant policy decisions, such as the
       Biodiscovery Bill.
       Monday, June 20 at 9:00 am, Room 203B
       Contact: Tina Radburn, (213) 346-0090,
     * BioAdvance -- Greater Philadelphia Life Sciences
       Study Findings
       BioAdvance will announce findings of a first-ever look at
       the Greater Philadelphia area's competitive position within
       the life sciences industry.  BioAdvance will release a June
       2005 Milken Institute study, titled "The Greater
       Philadelphia Life Sciences Cluster: An Economic and
       Competitive Assessment."
       Monday, June 20 at 10:00 am, Room 203B
       Contact: Ellen Semple, (215) 966-6207,
     * Victoria, Australia -- New Biomedical Announcements,
       Plus Latest Results in the Kangaroo Genomics Project
       Victoria Government Premier Steve Bracks, Treasurer
       John Brumby and Minister for Health Bronwyn Pike will
       deliver major biomedical announcements and the latest
       results in kangaroo genomics research projects.  Victoria is
       partnering with the US NIH on sequencing the kangaroo genome.
       Monday, June 20 at 10:00 am, Room 204A
       Contact: Trish Vardon, +61 (0)3 9651 9236,
     * British Columbia -- Hot Opportunities in North America
       British Columbia Premier Gordon Campbell will announce
       economic development incentives for the biotechnology
       industry in Canada.
       Monday, June 20 at 11:00 am, Room 203B
       Contact: Linda Thorstad, (604) 761-5046,
     * Singapore -- The Biopolis of Asia
       Singapore is dedicated to enhancing human healthcare as
       one of the world's most preeminent life sciences hubs.  The
       Singapore Economic Development Board will emphasize
       opportunities that currently exist in Singapore as a base for
       R&D investment and as a strategic location for Biomedical
       Sciences manufacturing.
       Monday, June 20 at 12:00 pm, Room 203B
       Contact: Daphne Teo, +65 6235 4495,
     * Invitrogen -- A New System for Disease Research
       Invitrogen will announce new research technologies geared
       toward specific disease models and pathways.  Invitrogen
       will introduce a system that ties its technologies together to
       target applications and pathways.
       Monday, June 20 at 2:00 pm, Room 203B
       Contact: Gregory L. Geissman, (760) 476-7032,
     * Wyeth & Dublin City University -- Collaboration on
       Advanced Technologies for Protein Expression
       Wyeth and Dublin City University have entered into a
       collaborative research agreement, with funding support
       from the Science Foundation of Ireland, to investigate gene
       expression pathways of cultured mammalian cells relevant
       to their industrial use in biopharmaceutical production.  The
       project will involve the use of genomics and proteomics
       technologies in the identification of genes expressed in
       Chinese hamster ovary cells that are important in
       supporting outstanding cell growth and protein
       productivity in production bioreactor cultures.
       Tuesday, June 21 at 11:00 am, Room 203B
       Contact: Gerald V. Burr, (484) 865-5138,
     * Commonwealth of Massachusetts -- Joint Scientific
       Research Collaborations between Massachusetts and
       the Ministry Of Education, University, and Research of
       the Italian Republic
       Massachusetts Governor Mitt Romney will sign a
       Memorandum of Understanding designed to further the
       establishment of bilateral networks and partnerships and to
       facilitate joint scientific, medical research and
       biotechnology development projects in Massachusetts and
       Tuesday, June 21 at 1:00 pm, Room 203B
       Contact: Amy Speer, (617) 788-3636,
     * Biotechnology Industry Organization -- The Value of
       Biotech Healthcare Therapies
       Amit Sachdev, BIO's Executive Vice President, Health,
       and Jayson Slotnick, BIO's Director, Medicare
       Reimbursement & Economic Policy, will release the
       results of a study on the value of biotech therapies.
       Tuesday, June 21 at 2:00 pm, Room 203B
       Contact: Jayson Slotnick, (202) 962-9200,
     * Montgomery County, Md. -- Maryland Welcomes
       Britain's Xceleron
       Xceleron, the world's foremost company using the
       nanotechnology of accelerator mass spectrometry in drug
       development, will announce its new North American
       Headquarters, to be located in Montgomery County,
       Maryland.  Xceleron's technologies have been proven to
       speed drug development and reduce attrition rates.
       Tuesday, June 21 at 3:00 pm, Room 203B
       Contact: Joseph H. Shapiro, (240) 777-2000,
     * MDS Pharma Services -- Biomarker Alliance Launch
       Dr. Jean W. Lee, Research Fellow, and Fred Pritchard,
       vice president, Drug Development Programs, of MDS
       Pharma Services will announce the formation of a
       biomarker alliance among a coalition of commercial and
       academic groups.
       Wednesday, June 22 at 11:00 am, Room 203B
       Contact: John F. Kouten, (908) 281-6099
     The complete up-to-date schedule of press conferences can be viewed on
 BIO's web site, at
     Media registration for the BIO 2005 Annual International Convention is
 complimentary for credentialed members of the news media.  Only reporters and
 editors working full-time for print or broadcast news organizations may
 register on site with valid, current media credentials (i.e. official picture
 identification from the employing news organization).  Everyone attending the
 conference must present valid photo identification to gain admittance.
 Without proper, approved credentials, on site media registration will be
 denied.  Freelance journalists, college publications and Web-based
 publications may not register on site at the conference.  Marketing, public
 relations executives, analysts, consultants, authors, and researchers may not
 register as media.  BIO reserves the right to limit the number of admission
 approvals from the same publication or news outlet.
     BIO represents more than 1,100 biotechnology companies, academic
 institutions, state biotechnology centers and related organizations across the
 United States and 31 other nations.  BIO members are involved in the research
 and development of healthcare, agricultural, industrial and environmental
 biotechnology products.

SOURCE Biotechnology Industry Organization